Loading

Closing Deals in Uncertain Times

June 22, 2026
25ABC
Type: Breakout Session
Focus Area: Business Development and Investment
Our industry has faced a variety of geopolitical and economic issues that inject uncertainty into deal-making. We must now navigate an unprecedented wave of legislation, executive orders, and policies covering most favored nation pricing, tariffs, data sharing restrictions, and domestic manufacturing, among others. In this panel, speakers will explore strategies for how to allocate risk and close deals in the face of this uncertainty. These dynamics require organizations to adopt more agile negotiation frameworks, strengthen interdisciplinary collaboration, and anticipate shifting regulatory interpretations, ensuring that transactions remain resilient, competitive, and aligned with rapidly evolving global expectations as well as commercial realities and pressures.
Moderator
Oren Livne, JD/BMA
Partner
Baker McKenzie
Speakers
Casarine Chong, JD
General Counsel, R&D, Business Development and Strategy
CSL
Chad Diehl, JD
Legal Team Lead, Licensing & Acquisitions and Alliance Management
Astellas Pharma
Ellen Lubman, MBA
Chief Business Officer
ReAlta Life Sciences
Deepa Talpade, PhD
Vice President, Head BD&L and Alliance Mgmt., Oncology
Bayer

white squarewhite

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS

Loading